{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:36:39Z","timestamp":1787315799111,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA043535"],"award-info":[{"award-number":["R01DA043535"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA051295"],"award-info":[{"award-number":["R01DA051295"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Impaired decision-making is often seen in people with bipolar disorder (BD), even those undergoing treatment. Targeted therapeutics are therefore needed. People with BD report that cannabis use (CU) attenuates such cognitive and behavioral symptoms. We hypothesized that 1) people with BD who do not use cannabis would exhibit poor decision-making and functional capacity relative to healthy comparison (HC) participants and 2) CU in people with BD would be associated with decision-making and functional capacity comparable to that of HC participants who do not use cannabis. HC and BD participants that either reported regular (\u22654x\/weekly) CU or no-CU were recruited (n\u2009=\u200987). Participants were tested on decision-making and functional capacity using the Iowa Gambling Task and UCSD Performance-based skills assessment (UPSA-2), respectively. CU was associated with impaired decision-making in healthy participants while CU in participants with BD was associated with better decision-making than their non-using counterparts and equivalent to decision-making in non-CU HC participants. Additionally, CU in people with BD was associated with UPSA-2 scores comparable to non-CU HC participants. Studies are needed to determine whether cannabinoid-related treatments improve such decision-making and function in people with BD.<\/jats:p>","DOI":"10.1038\/s41398-025-03718-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:39:11Z","timestamp":1764250751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants"],"prefix":"10.1038","volume":"15","author":[{"given":"Alannah","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Z.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna M.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holden","family":"Rosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1846-3232","authenticated-orcid":false,"given":"Samantha M.","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2983-774X","authenticated-orcid":false,"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Mook","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel A.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Geyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-5776","authenticated-orcid":false,"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"3718_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4088\/JCP.v64n0610","volume":"64","author":"RM Post","year":"2003","unstructured":"Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64:680\u201390.","journal-title":"J Clin Psychiatry"},{"key":"3718_CR2","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.psychres.2010.07.007","volume":"185","author":"A Agrawal","year":"2011","unstructured":"Agrawal A, Nurnberger JI, Lynskey MT. Cannabis involvement in individuals with bipolar disorder. Psychiatry Res. 2011;185:459.","journal-title":"Psychiatry Res"},{"key":"3718_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/17523281.2012.659751","volume":"5","author":"SA Gruber","year":"2012","unstructured":"Gruber SA, Sagar KA, Dahlgren MK, Olson DP, Centorrino F, Lukas SE. Marijuana impacts mood in bipolar disorder: a pilot study. Ment Health Subst Use. 2012;5:228\u201339.","journal-title":"Ment Health Subst Use"},{"key":"3718_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 2011;124:250\u201361.","journal-title":"Acta Psychiatr Scand"},{"key":"3718_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02791072.1998.10399687","volume":"30","author":"L Grinspoon","year":"1998","unstructured":"Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoact Drugs. 1998;30:171\u20137.","journal-title":"J Psychoact Drugs"},{"key":"3718_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1369-1600.2008.00106.x","volume":"13","author":"FM Leweke","year":"2008","unstructured":"Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addiction Biol. 2008;13:264\u201375.","journal-title":"Addiction Biol"},{"key":"3718_CR7","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/00952990.2019.1634086","volume":"45","author":"AC Burggren","year":"2019","unstructured":"Burggren AC, Shirazi A, Ginder N, London ED. Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives. Am J Drug Alcohol Abus. 2019;45:563\u201379.","journal-title":"Am J Drug Alcohol Abus"},{"key":"3718_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s40473-021-00244-7","volume":"8","author":"JM Ellingson","year":"2021","unstructured":"Ellingson JM, Hinckley JD, Ross JM, Schacht JP, Bidwell LC, Bryan AD, et al. The neurocognitive effects of cannabis across the lifespan. Curr Behav Neurosci Rep. 2021;8:124\u201333.","journal-title":"Curr Behav Neurosci Rep"},{"key":"3718_CR9","doi-asserted-by":"publisher","unstructured":"Walter TJ, Pocuca N, Young JW, Geyer MA, Minassian A, Perry W. The relationship between cannabis use and cognition in people with bipolar disorder: a systematic scoping review. Psychiatry Res 2021;297. https:\/\/doi.org\/10.1016\/J.PSYCHRES.2020.113695.","DOI":"10.1016\/J.PSYCHRES.2020.113695"},{"key":"3718_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psychres.2012.05.025","volume":"200","author":"RJ Braga","year":"2012","unstructured":"Braga RJ, Burdick KE, DeRosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012;200:242\u20135.","journal-title":"Psychiatry Res"},{"key":"3718_CR11","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1017\/S0033291709991620","volume":"40","author":"PA Ringen","year":"2010","unstructured":"Ringen PA, Vaskinn A, Sundet K, Engh JA, J\u00f3nsd\u00f3ttir H, Simonsen C, et al. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med. 2010;40:1337\u201347.","journal-title":"Psychol Med"},{"key":"3718_CR12","doi-asserted-by":"crossref","unstructured":"Halder A, Chakraborty A, Bose S Correlations of cannabis use of human cognition and bipolar disorder. Indian J Psychiatry 2015;57.","DOI":"10.4103\/0019-5545.161488"},{"key":"3718_CR13","first-page":"60","volume":"21","author":"TV Lagerberg","year":"2019","unstructured":"Lagerberg TV, Melle I, Ringen PA, Aminoff SR, Buchmann C, Hoegh MC, et al. The relationship between cannabis use, cognitive functioning and polygenic risk in bipolar disorder. Bipolar Disord. 2019;21:60\u20131.","journal-title":"Bipolar Disord"},{"key":"3718_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.pscychresns.2018.03.008","volume":"276","author":"H Abush","year":"2018","unstructured":"Abush H, Ghose S, Van Enkevort EA, Clementz BA, Pearlson GD, Sweeney JA, et al. Associations between adolescent cannabis use and brain structure in psychosis. Psychiatry Res Neuroimaging. 2018;276:53\u201364.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"3718_CR15","doi-asserted-by":"publisher","first-page":"e0157060","DOI":"10.1371\/journal.pone.0157060","volume":"11","author":"KA Sagar","year":"2016","unstructured":"Sagar KA, Dahlgren MK, Racine MT, Dreman MW, Olson DP, Gruber SA. Joint effects: a pilot investigation of the impact of bipolar disorder and marijuana use on cognitive function and mood. PLoS One. 2016;11:e0157060.","journal-title":"PLoS One"},{"key":"3718_CR16","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00213-021-06047-8","volume":"239","author":"J Leung","year":"2022","unstructured":"Leung J, Chan G, Stjepanovi\u0107 D, Chung JYC, Hall W, Hammond D. Prevalence and self-reported reasons of cannabis use for medical purposes in USA and Canada. Psychopharmacology (Berl). 2022;239:1509.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.biopsych.2011.01.018","volume":"70","author":"M Adida","year":"2011","unstructured":"Adida M, Jollant F, Clark L, Besnier N, Guillaume S, Kaladjian A, et al. Trait-related decision-making impairment in the three phases of bipolar disorder. Biol Psychiatry. 2011;70:357\u201365.","journal-title":"Biol Psychiatry"},{"key":"3718_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0010-0277(94)90018-3","volume":"50","author":"A Bechara","year":"1994","unstructured":"Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. 1994;50:7\u201315.","journal-title":"Cognition"},{"key":"3718_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/pchj.351","volume":"9","author":"Yting Gu","year":"2020","unstructured":"Gu Yting, Zhou C, Yang J, Zhang Q, Zhu Ghui, Sun L, et al. A transdiagnostic comparison of affective decision-making in patients with schizophrenia, major depressive disorder, or bipolar disorder. Psych J. 2020;9:199\u2013209.","journal-title":"Psych J"},{"key":"3718_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00213-017-4543-7","volume":"234","author":"M Milienne-Petiot","year":"2017","unstructured":"Milienne-Petiot M, Geyer MA, Arnt J, Young JW. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology (Berl). 2017;234:1017\u201328.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00213-012-2854-2","volume":"225","author":"J Van Enkhuizen","year":"2013","unstructured":"Van Enkhuizen J, Geyer MA, Young JW. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology (Berl). 2013;225:661\u201374.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR22","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/npp.2009.62","volume":"34","author":"FD Zeeb","year":"2009","unstructured":"Zeeb FD, Robbins TW, Winstanley CA. Serotonergic and dopaminergic modulation of gambling behavior as assessed using a novel rat gambling task. Neuropsychopharmacology. 2009;34:2329\u201343.","journal-title":"Neuropsychopharmacology"},{"key":"3718_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","volume":"31","author":"JW Young","year":"2007","unstructured":"Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the behavioral pattern monitor. Neurosci Biobehav Rev. 2007;31:882\u201396.","journal-title":"Neurosci Biobehav Rev"},{"key":"3718_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","volume":"66","author":"W Perry","year":"2009","unstructured":"Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, et al. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry. 2009;66:1072\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"3718_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/bdi.12786","volume":"22","author":"JW Young","year":"2020","unstructured":"Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, et al. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disord. 2020;22:46\u201358.","journal-title":"Bipolar Disord"},{"key":"3718_CR26","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/0269881111400646","volume":"25","author":"JW Young","year":"2011","unstructured":"Young JW, Van Enkhuizen J, Winstanley CA, Geyer MA. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J Psychopharmacol. 2011;25:934\u201343.","journal-title":"J Psychopharmacol"},{"key":"3718_CR27","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1038\/npp.2014.170","volume":"39","author":"J van Enkhuizen","year":"2014","unstructured":"van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, et al. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology. 2014;39:3112\u201322.","journal-title":"Neuropsychopharmacology"},{"key":"3718_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","volume":"13","author":"A Anand","year":"2011","unstructured":"Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH, et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13:406\u201313.","journal-title":"Bipolar Disord"},{"key":"3718_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2022.3541","volume":"79","author":"LN Yatham","year":"2022","unstructured":"Yatham LN, Liddle PF, Gonzalez M, Saraf G, Vafai N, Lam RW, et al. A positron emission tomography study of dopamine transporter density in patients with bipolar disorder with current mania and those with recently remitted mania. JAMA Psychiatry. 2022;79:1217\u201324.","journal-title":"JAMA Psychiatry"},{"key":"3718_CR30","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","volume":"105","author":"TA Greenwood","year":"2001","unstructured":"Greenwood TA, Alexander M, Keck PE, Mcelroy S, Sadovnick AD, Remick RA, et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. American J Med Genet (Neuropsychiatr Genet). 2001;105:145\u201351.","journal-title":"American J Med Genet (Neuropsychiatr Genet)"},{"key":"3718_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.mp.4001764","volume":"11","author":"TA Greenwood","year":"2006","unstructured":"Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry. 2006;11:125\u201333.","journal-title":"Mol Psychiatry"},{"key":"3718_CR32","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1073\/pnas.98.4.1982","volume":"98","author":"X Zhuang","year":"2001","unstructured":"Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc Natl Acad Sci USA. 2001;98:1982\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3718_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000106476","volume":"55","author":"JD Amsterdam","year":"2007","unstructured":"Amsterdam JD, Newberg AB. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology. 2007;55:167\u201370.","journal-title":"Neuropsychobiology"},{"key":"3718_CR34","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1007\/s00213-015-4000-4","volume":"232","author":"J van Enkhuizen","year":"2015","unstructured":"van Enkhuizen J, Milienne-Petiot M, Geyer MA, Young JW. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. Psychopharmacology (Berl). 2015;232:3455\u201367.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/npp.2015.192","volume":"41","author":"M Kohno","year":"2016","unstructured":"Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, et al. Functional genetic variation in dopamine signaling moderates prefrontal cortical activity during risky decision making. Neuropsychopharmacology. 2016;41:695\u2013703.","journal-title":"Neuropsychopharmacology"},{"key":"3718_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0278-5846(01)00162-2","volume":"25","author":"M Glass","year":"2001","unstructured":"Glass M. The role of cannabinoids in neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:743\u201365.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"3718_CR37","doi-asserted-by":"publisher","first-page":"2723","DOI":"10.1007\/s00213-015-3915-0","volume":"232","author":"MG Bossong","year":"2015","unstructured":"Bossong MG, Mehta MA, Berckel BNM, van, Howes OD, Kahn RS, et al. Further human evidence for striatal dopamine release induced by administration of \u03949-tetrahydrocannabinol (THC): selectivity to limbic striatum. Psychopharmacology (Berl). 2015;232:2723.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbr.2016.05.045","volume":"311","author":"BB Tournier","year":"2016","unstructured":"Tournier BB, Tsartsalis S, Dimiziani A, Millet P, Ginovart N. Time-dependent effects of repeated THC treatment on dopamine D2\/3 receptor-mediated signalling in midbrain and striatum. Behavioural brain Res. 2016;311:322\u20139.","journal-title":"Behavioural brain Res"},{"key":"3718_CR39","doi-asserted-by":"publisher","unstructured":"Tournier BB, Dimiziani A, Tsartsalis S, Millet P, Ginovart N. Different effects of chronic THC on the neuroadaptive response of dopamine D2\/3 receptor-mediated signaling in roman high- and roman low-avoidance rats. Synapse 2018; 72. https:\/\/doi.org\/10.1002\/SYN.22023.","DOI":"10.1002\/SYN.22023"},{"key":"3718_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/mpr.1379","volume":"22","author":"M Lukasiewicz","year":"2013","unstructured":"Lukasiewicz M, Gerard S, Besnard A, Falissard B, Perrin E, Sapin H, et al. Young mania rating scale: how to interpret the numbers? determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int J Methods Psychiatr Res. 2013;22:46.","journal-title":"Int J Methods Psychiatr Res"},{"key":"3718_CR41","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","volume":"150","author":"M Zimmerman","year":"2013","unstructured":"Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150:384\u20138.","journal-title":"J Affect Disord"},{"key":"3718_CR42","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/npp.2015.108","volume":"40","author":"M Haney","year":"2015","unstructured":"Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers. Neuropsychopharmacology. 2015;40:2489\u201398.","journal-title":"Neuropsychopharmacology"},{"key":"3718_CR43","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/npp.2013.324","volume":"39","author":"EA Henry","year":"2014","unstructured":"Henry EA, Kaye JT, Bryan AD, Hutchison KE, Ito TA. Cannabis cue reactivity and craving among never, infrequent and heavy cannabis users. Neuropsychopharmacology. 2014;39:1214\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"3718_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1037\/abn0000224","volume":"126","author":"S Papini","year":"2017","unstructured":"Papini S, Ruglass LM, Lopez-Castro T, Powers MB, Smits JAJ, Hien DA. Chronic cannabis use is associated with impaired fear extinction in humans. J Abnorm Psychol. 2017;126:117\u201324.","journal-title":"J Abnorm Psychol"},{"key":"3718_CR45","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0269881108092393","volume":"23","author":"JG Ramaekers","year":"2009","unstructured":"Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol. 2009;23:266\u201377.","journal-title":"J Psychopharmacol"},{"key":"3718_CR46","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1176\/appi.ajp.159.12.2013","volume":"159","author":"EW Twamley","year":"2002","unstructured":"Twamley EW, Doshi RR, Nayak GV, Palmer BW, Golshan S, Heaton RK, et al. Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am J Psychiatry. 2002;159:2013\u201320.","journal-title":"Am J Psychiatry"},{"key":"3718_CR47","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","volume":"59","author":"KI Bolla","year":"2002","unstructured":"Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59:1337\u201343.","journal-title":"Neurology"},{"key":"3718_CR48","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09540121.2015.1124983","volume":"28","author":"AD Thames","year":"2016","unstructured":"Thames AD, Mahmood Z, Burggren AC, Karimian A, Kuhn TP. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status. AIDS Care. 2016;28:628\u201332.","journal-title":"AIDS Care"},{"key":"3718_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/S11904-024-00698-W","volume":"21","author":"SM Ayoub","year":"2024","unstructured":"Ayoub SM, Holloway BM, Miranda AH, Roberts BZ, Young JW, Minassian A, et al. The impact of cannabis use on cognition in people with hiv: evidence of function-dependent effects and mechanisms from clinical and preclinical studies. Curr HIV\/AIDS Rep. 2024;21:87\u2013115. https:\/\/doi.org\/10.1007\/S11904-024-00698-W.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"3718_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.596601","volume":"12","author":"J Bourque","year":"2021","unstructured":"Bourque J, Potvin S. Cannabis and cognitive functioning: from acute to residual effects, from randomized controlled trials to prospective designs. Front Psychiatry. 2021;12:596601.","journal-title":"Front Psychiatry"},{"key":"3718_CR51","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2017.16","volume":"22","author":"AH Ashok","year":"2017","unstructured":"Ashok AH, Marques TR, Jauhar S, Nour MM, Goodwin GM, Young AH, et al. The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry. 2017;22:666\u201379.","journal-title":"Mol Psychiatry"},{"key":"3718_CR52","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/syn.20648","volume":"63","author":"FJS Lee","year":"2009","unstructured":"Lee FJS, Pei L, Liu F. Disruption of the dopamine transporter-dopamine D2 receptor interaction in schizophrenia. Synapse. 2009;63:710\u20132.","journal-title":"Synapse"},{"key":"3718_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1399-5618.2009.00771.x","volume":"12","author":"TT Chang","year":"2010","unstructured":"Chang TT, Yeh TL, Chiu NT, Chen PS, Huang HY, Yang YK, et al. Higher striatal dopamine transporters in euthymic patients with bipolar disorder: a SPECT study with [Tc] TRODAT-1. Bipolar Disord. 2010;12:102\u20136.","journal-title":"Bipolar Disord"},{"key":"3718_CR54","doi-asserted-by":"publisher","first-page":"e9.","DOI":"10.1192\/J.EURPSY.2021.1","volume":"64","author":"Y-S Hsueh","year":"2021","unstructured":"Hsueh Y-S, Lin C-Y, Chiu N-T, Yang YK, Chen PS, Chang HH. Changes in striatal dopamine transporters in bipolar disorder and valproate treatment. Eur Psychiatry. 2021;64:e9. https:\/\/doi.org\/10.1192\/J.EURPSY.2021.1.","journal-title":"Eur Psychiatry"},{"key":"3718_CR55","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jpsychires.2023.07.024","volume":"165","author":"YT Tsai","year":"2023","unstructured":"Tsai YT, Chang CY, Wu CY, Huang YL, Chang HH, Lu TH, et al. Social cognitive deficit is associated with visuomotor coordination impairment and dopamine transporter availability in euthymic bipolar disorder. J Psychiatr Res. 2023;165:158\u201364.","journal-title":"J Psychiatr Res"},{"key":"3718_CR56","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","volume":"157","author":"A Anand","year":"2000","unstructured":"Anand A, Verhoeff P, Seneca N, Zoghbi SS, Seibyl JP, Charney DS, et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry. 2000;157:1108\u201314.","journal-title":"Am J Psychiatry"},{"key":"3718_CR57","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jad.2021.08.022","volume":"295","author":"G Saraf","year":"2021","unstructured":"Saraf G, Pinto JV, Cahn A, White AG, Shahinfard E, Vafai N, et al. Dopamine release during psychological stress in euthymic bipolar i disorder: a positron emission tomography study with [11c]raclopride. J Affect Disord. 2021;295:724\u201332.","journal-title":"J Affect Disord"},{"key":"3718_CR58","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuroimage.2015.03.022","volume":"113","author":"LM Oswald","year":"2015","unstructured":"Oswald LM, Wand GS, Wong DF, Brown CH, Kuwabara H, Bra\u0161i\u0107 JR. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults. Neuroimage. 2015;113:26\u201336.","journal-title":"Neuroimage"},{"key":"3718_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1467-9450.2010.00837.x","volume":"52","author":"J Linnet","year":"2011","unstructured":"Linnet J, M\u00f8ller A, Peterson E, Gjedde A, Doudet D. Inverse association between dopaminergic neurotransmission and iowa gambling task performance in pathological gamblers and healthy controls. Scand J Psychol. 2011;52:28\u201334.","journal-title":"Scand J Psychol"},{"key":"3718_CR60","first-page":"759","volume":"34","author":"MG Bossong","year":"2008","unstructured":"Bossong MG, Van Berckel BNM, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, et al. \u03949-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 2009. 2008;34:759\u201366.","journal-title":"Neuropsychopharmacology 2009"},{"key":"3718_CR61","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.neuroimage.2010.04.274","volume":"52","author":"PRA Stokes","year":"2010","unstructured":"Stokes PRA, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, et al. Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage. 2010;52:1521\u20137.","journal-title":"Neuroimage"},{"key":"3718_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0006-8993(88)90749-4","volume":"451","author":"JMNC Ton","year":"1988","unstructured":"Ton JMNC, Gerhardt GA, Friedemann M, Etgen AM, Rose GM, Sharpless NS, et al. The effects of delta 9-tetrahydrocannabinol on potassium-evoked release of dopamine in the rat caudate nucleus: an in vivo electrochemical and in vivo microdialysis study. Brain Res. 1988;451:59\u201368.","journal-title":"Brain Res"},{"key":"3718_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/BF02245916","volume":"102","author":"J Chen","year":"1990","unstructured":"Chen J, Paredes W, Li J, Smith D, Lowinson J, Gardner EL. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berl). 1990;102:156\u201362.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","volume":"948","author":"M Pistis","year":"2002","unstructured":"Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, et al. \u03949-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: An in vivo microdialysis study. Brain Res. 2002;948:155\u20138.","journal-title":"Brain Res"},{"key":"3718_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","volume":"75","author":"MAP Bloomfield","year":"2014","unstructured":"Bloomfield MAP, Morgan CJA, Egerton A, Kapur S, Curran HV, Howes OD. Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms. Biol Psychiatry. 2014;75:470\u20138.","journal-title":"Biol Psychiatry"},{"key":"3718_CR66","doi-asserted-by":"publisher","first-page":"E3149","DOI":"10.1073\/PNAS.1411228111","volume":"111","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J, et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci USA. 2014;111:E3149\u201356. https:\/\/doi.org\/10.1073\/PNAS.1411228111.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3718_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/mp.2016.21","volume":"22","author":"E Van De Giessen","year":"2017","unstructured":"Van De Giessen E, Weinstein JJ, Cassidy CM, Haney M, Dong Z, Ghazzaoui R, et al. Deficits in striatal dopamine release in cannabis dependence. Mol Psychiatry. 2017;22:68\u201375.","journal-title":"Mol Psychiatry"},{"key":"3718_CR68","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature20153","volume":"539","author":"MAP Bloomfield","year":"2016","unstructured":"Bloomfield MAP, Ashok AH, Volkow ND, Howes OD. The effects of \u03949-tetrahydrocannabinol on the dopamine system. Nature. 2016;539:369.","journal-title":"Nature"},{"key":"3718_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13659-020-00263-z","volume":"10","author":"S Chetia","year":"2020","unstructured":"Chetia S, Borah Gaurab, Chetia S, Borah G. \u0394 9-tetrahydrocannabinol toxicity and validation of cannabidiol on brain dopamine levels: an assessment on cannabis duplicity. Natural Products Bioprospecting. 2020;10:285\u201396.","journal-title":"Natural Products Bioprospecting"},{"key":"3718_CR70","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2004.04.009","volume":"76","author":"CT Whitlow","year":"2004","unstructured":"Whitlow CT, Liguori A, Brooke Livengood L, Hart SL, Mussat-Whitlow BJ, Lamborn CM, et al. Long-term heavy marijuana users make costly decisions on a gambling task. Drug Alcohol Depend. 2004;76:107\u201311.","journal-title":"Drug Alcohol Depend"},{"key":"3718_CR71","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.neuroimage.2005.02.012","volume":"26","author":"KI Bolla","year":"2005","unstructured":"Bolla KI, Eldreth DA, Matochik JA, Cadet JL. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage. 2005;26:480\u201392.","journal-title":"Neuroimage"},{"key":"3718_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jmp.2009.10.002","volume":"54","author":"DJ Fridberg","year":"2010","unstructured":"Fridberg DJ, Queller S, Ahn WY, Kim W, Bishara AJ, Busemeyer JR, et al. Cognitive mechanisms underlying risky decision-making in chronic cannabis users. J Math Psychol. 2010;54:28\u201338.","journal-title":"J Math Psychol"},{"key":"3718_CR73","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pscychresns.2010.10.002","volume":"191","author":"MJ Wesley","year":"2011","unstructured":"Wesley MJ, Hanlon CA, Porrino LJ. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res. 2011;191:51\u20139.","journal-title":"Psychiatry Res"},{"key":"3718_CR74","doi-asserted-by":"publisher","first-page":"e66387","DOI":"10.1371\/JOURNAL.PONE.0066387","volume":"8","author":"AB Fagundo","year":"2013","unstructured":"Fagundo AB, de la Torre R, Jim\u00e9nez-Murcia S, Ag\u00fcera Z, Pastor A, Casanueva FF, et al. Modulation of the endocannabinoids n-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG) on executive functions in humans. PLoS One. 2013;8:e66387. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0066387.","journal-title":"PLoS One"},{"key":"3718_CR75","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00213-009-1744-8","volume":"208","author":"JW Young","year":"2010","unstructured":"Young JW, Goey AKL, Minassian A, Perry W, Paulus MP, Geyer MA. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl). 2010;208:443\u201354.","journal-title":"Psychopharmacology (Berl)"},{"key":"3718_CR76","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pbb.2010.03.014","volume":"96","author":"JW Young","year":"2010","unstructured":"Young JW, Goey AKL, Minassian A, Perry W, Paulus MP, Geyer MA. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacol Biochem Behav. 2010;96:7\u201315.","journal-title":"Pharmacol Biochem Behav"},{"key":"3718_CR77","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","volume":"282","author":"CP Ford","year":"2014","unstructured":"Ford CP. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience. 2014;282:13\u201322.","journal-title":"Neuroscience"},{"key":"3718_CR78","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/J.BPSC.2023.04.012","volume":"8","author":"AM Soehner","year":"2023","unstructured":"Soehner AM, Wallace ML, Edmiston K, Chase H, Lockovich J, Aslam H, et al. Neurobehavioral reward and sleep-circadian profiles predict present and next-year mania\/hypomania symptoms. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8:1251\u201361. https:\/\/doi.org\/10.1016\/J.BPSC.2023.04.012.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"3718_CR79","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.psychres.2013.04.006","volume":"210","author":"BL Henry","year":"2013","unstructured":"Henry BL, Minassian A, Perry W. Everyday functional ability across different phases of bipolar disorder. Psychiatry Res. 2013;210:850\u20136.","journal-title":"Psychiatry Res"},{"key":"3718_CR80","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/15504263.2019.1674991","volume":"16","author":"L Sideli","year":"2019","unstructured":"Sideli L, Quigley H, La Cascia C, Murray RM. Cannabis use and the risk for psychosis and affective disorders. J Dual Diagn. 2019;16:22\u201342.","journal-title":"J Dual Diagn"},{"key":"3718_CR81","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00406-011-0188-4","volume":"261","author":"TV Lagerberg","year":"2011","unstructured":"Lagerberg TV, Sundet K, Aminoff SR, Berg AO, Ringen PA, Andreassen OA, et al. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2011;261:397\u2013405.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"3718_CR82","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neubiorev.2019.04.004","volume":"101","author":"JV Pinto","year":"2019","unstructured":"Pinto JV, Medeiros LS, Santana da Rosa G, Santana de Oliveira CE, Crippa JA, de S, et al. The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: a systematic review with meta-analysis and meta-regression. Neurosci Biobehav Rev. 2019;101:78\u201384.","journal-title":"Neurosci Biobehav Rev"},{"key":"3718_CR83","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15504263.2022.2053264","volume":"18","author":"A Selloni","year":"2022","unstructured":"Selloni A, Bhatia G, Ranganathan M, De Aquino JP. Multimodal correlates of cannabis use among U.S. veterans with bipolar disorder: an integrated study of clinical, cognitive, and functional outcomes. J Dual Diagn. 2022;18:81\u201391.","journal-title":"J Dual Diagn"},{"key":"3718_CR84","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4236\/jbbs.2020.108022","volume":"10","author":"KJ Kallianpur","year":"2020","unstructured":"Kallianpur KJ, Birn R, Ndhlovu LC, Souza SA, Mitchell B, Paul R, et al. Impact of cannabis use on brain structure and function in suppressed HIV infection. J Behav Brain Sci. 2020;10:344.","journal-title":"J Behav Brain Sci"},{"key":"3718_CR85","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.drugalcdep.2017.09.023","volume":"181","author":"I Kov\u00e1cs","year":"2017","unstructured":"Kov\u00e1cs I, Richman MJ, Janka Z, Maraz A, And\u00f3 B. Decision making measured by the iowa gambling task in alcohol use disorder and gambling disorder: a systematic review and meta-analysis. Drug Alcohol Depend. 2017;181:152\u201361.","journal-title":"Drug Alcohol Depend"},{"key":"3718_CR86","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.eurpsy.2007.06.001","volume":"22","author":"F Jollant","year":"2007","unstructured":"Jollant F, Guillaume S, Jaussent I, Bellivier F, Leboyer M, Castelnau D, et al. Psychiatric diagnoses and personality traits associated with disadvantageous decision-making. Eur Psychiatry. 2007;22:455\u201361.","journal-title":"Eur Psychiatry"},{"key":"3718_CR87","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/ADM.0000000000000065","volume":"8","author":"M Balconi","year":"2014","unstructured":"Balconi M, Finocchiaro R, Campanella S. Reward sensitivity, decisional bias, and metacognitive deficits in cocaine drug addiction. J Addict Med. 2014;8:399\u2013406.","journal-title":"J Addict Med"},{"key":"3718_CR88","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.psychres.2013.01.030","volume":"207","author":"M Gorlyn","year":"2013","unstructured":"Gorlyn M, Keilp JG, Oquendo MA, Burke AK, John Mann J. Iowa gambling task performance in currently depressed suicide attempters. Psychiatry Res. 2013;207:150\u20137.","journal-title":"Psychiatry Res"},{"key":"3718_CR89","doi-asserted-by":"publisher","first-page":"706933","DOI":"10.3389\/FPSYT.2021.706933","volume":"12","author":"P Zakowicz","year":"2021","unstructured":"Zakowicz P, Skibi\u0144ska M, Wasicka-Przewo\u017ana K, Skulimowski B, Wa\u015bniewski F, Chorzepa A, et al. Impulsivity as a risk factor for suicide in bipolar disorder. Front Psychiatry. 2021;12:706933. https:\/\/doi.org\/10.3389\/FPSYT.2021.706933.","journal-title":"Front Psychiatry"},{"key":"3718_CR90","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.neubiorev.2021.10.005","volume":"131","author":"A Sastre-Buades","year":"2021","unstructured":"Sastre-Buades A, Alacreu-Crespo A, Courtet P, Baca-Garcia E, Barrigon ML. Decision-making in suicidal behavior: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;131:642\u201362.","journal-title":"Neurosci Biobehav Rev"},{"key":"3718_CR91","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2105\/AJPH.2017.303654","volume":"107","author":"JP Reis","year":"2017","unstructured":"Reis JP, Auer R, Bancks MP, Goff DC, Lewis CE, Pletcher MJ, et al. Cumulative lifetime marijuana use and incident cardiovascular disease in middle age: the coronary artery risk development in young adults (CARDIA) study. Am J Public Health. 2017;107:601.","journal-title":"Am J Public Health"},{"key":"3718_CR92","first-page":"72","volume":"30","author":"C Teigland","year":"2023","unstructured":"Teigland C, Mohammadi I, Agatep BC, Boskovic DH, Sajatovic M. Relationship between social determinants of health and hospitalizations and costs among patients with bipolar disorder 1. J Manag Care Spec Pharm. 2023;30:72.","journal-title":"J Manag Care Spec Pharm"},{"key":"3718_CR93","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1002\/nur.22389","volume":"47","author":"S O\u2019Donnell","year":"2024","unstructured":"O\u2019Donnell S, Scott-Storey K, Malcolm J, Vincent CD, Wuest J. Cumulative lifetime violence, social determinants of health, and cannabis use disorder post-cannabis legalization in a community sample of men: an intersectional perspective. Res Nurs Health. 2024;47:460\u201374.","journal-title":"Res Nurs Health"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03718-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03718-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T14:04:03Z","timestamp":1764252243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-025-03718-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3718"],"URL":"https:\/\/doi.org\/10.1038\/s41398-025-03718-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"506"}}